SHENZHEN HEPALINK PHARMACEUTICAL
(HKEX: 9989)
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China.
4.860 -
-0.050
(-1.02%)
Range
4.850 - 4.900
(1.03%)
Open
4.900
Previous Close
4.910
Bid Price
4.860
Bid Volume
('000)
51.5
Ask Price
4.900
Ask Volume
('000)
4.5
Volume
('000)
274.5
Value
1,336,408
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
